Citations 53

Efficacy of biological agents in the treatment of Erdheim‐Chester disease

British Journal of Haematology | October 30, 2017 | Volume: 183 | Issue: 3 | Pages: 520-524

10.1111/bjh.14997 | PMID 29082516

Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey

American Journal of Hematology | July 21, 2017 | Volume: 92 | Issue: 11 | Pages: No page available

10.1002/ajh.24866 | PMID 28730596

Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long‐term outcomes

British Journal of Haematology | June 27, 2017 | Volume: 182 | Issue: 4 | Pages: 579-581

10.1111/bjh.14818 | PMID 28653448

High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia

American Journal of Hematology | April 24, 2017 | Volume: 92 | Issue: 8 | Pages: No page available

10.1002/ajh.24765 | PMID 28437873

Clinical anatomy leading the way for solutions: An important paradigm for translational research

Clinical Anatomy | August 31, 2016 | Volume: 29 | Issue: 8 | Pages: 978-979

10.1002/ca.22782 | PMID 27576851

Erythromelalgia in patients with essential thrombocythemia and polycythemia vera

Leukemia & Lymphoma | August 10, 2016 | Volume: 58 | Issue: 3 | Pages: 715-717

10.1080/10428194.2016.1205740 | PMID 27684959

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history

European Journal of Haematology | June 3, 2014 | Volume: 94 | Issue: 1 | Pages: 31-36

10.1111/ejh.12389 | PMID 24889737

AbstractBackgroundVascular events in essential thrombocythemia (ET) are associated with advanced age and thrombosis history. Recent information suggests additional effect from the presence of specific mutations.ObjectivesTo examine the influence of age and thrombosis history on the reported association between mutational status and thrombosis‐free survival in ET.Patients and MethodsAnalysis was performed using a Mayo Clinic cohort of 300 ET patients, and key findings were reanalyzed by including additional 102 Italian patients.ResultsAmong 300 Mayo patients with ET (median age 55 yr, 60% females), mutational frequencies were 53% JAK2, 32% CALR, 3% MPL, and 12% JAK2, CALR and MPL wild type. One hundred and six (35%) patients experienced arterial (n = 75) or venous (n = 43) events, before (n = 55) or after (n = 71) diagnosis. In univariate analysis, compared to JAK2‐mutated cases, JAK2, CALR and MPL wild type (HR 0.31, 95% CI 0.11–0.86), and CALR‐mutated (0.53, 95% CI 0.30–0.92) patients displayed better thrombosis‐free survival. JAK2, CALR, and MPL wild type remained significant (P = 0.03; HR 0.32, 95% CI 0.11–0.9) during multivariable analysis that included age (P = 0.01) and thrombosis history (P = 0.0006); a favorable impact from CALR mutations was of borderline significance (P = 0.1; HR 0.62, 95% CI 0.35–1.1), but became significant (P = 0.02) when multivariable analysis including thrombosis history (P = 0.02) was performed on patients younger than 60 yr of age.ConclusionsThe favorable impact of mutational status on thrombosis‐free survival in ET might be most evident for JAK2, CALR, and MPL wild type patients, whereas the favorable effect from CALR mutations might be confined to young patients.
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

American Journal of Hematology | April 19, 2014 | Volume: 89 | Issue: 8 | Pages: No page available

10.1002/ajh.23743 | PMID 24753125

CALR (calreticulin) trails JAK 2 as the second most mutated gene in essential thrombocythemia (ET). Mutant CALR in ET is a result of frameshift mutations, caused by exon 9 deletions or insertions; type‐1, 52‐bp deletion (p.L367fs*46), and type‐2, 5‐bp TTGTC insertion (p.K385fs*47) variants constitute more than 80% of these mutations. The current study includes a total of 1027 patients divided into test ( n = 402) and validation ( n = 625) cohorts. Among the 402 ET patients in the test cohort, 227 (57%) harbored JAK 2, 11 (3%) Myeloproliferative leukemia virus oncogene ( MPL ), and 114 (28%) CALR mutations; 12% were wild‐type for all three mutations (i.e., triple‐negative). Among the 114 patients with CALR mutations, 51 (45%) displayed type‐1 and 44 (39%) type‐2 variants; compared to mutant JAK 2, both variants were associated with higher platelet and lower hemoglobin and leukocyte counts. However, male sex was associated with only type‐1 ( P = 0.005) and younger age with type‐2 ( P = 0.001) variants. Notably, platelet count was significantly higher in type‐2 vs. type‐1 CALR ‐mutated patients ( P = 0.03) and the particular observation was validated in the validation cohort that included 111 CALR ‐mutated ET patients ( P = 0.002). These findings, coupled with the recent demonstration of preferential expression of mutant and wild‐type CALR in megakaryocytes, suggest differential effects of CALR variants on thrombopoiesis. Am. J. Hematol. 89:E121–E124, 2014. © 2014 Wiley Periodicals, Inc.
Imatinib‐associated melanosis of the palate

American Journal of Hematology | September 13, 2013 | Volume: 89 | Issue: 5 | Pages: 564-564

10.1002/ajh.23589 | PMID 24030927

A prospective, randomized crossover study comparing direct inspection by light microscopy versus projected images for teaching of hematopathology to medical students

Anatomical Sciences Education | May 28, 2013 | Volume: 7 | Issue: 2 | Pages: 130-134

10.1002/ase.1374 | PMID 23716270

Instruction in hematopathology at Mayo Medical School has evolved from instructor‐guided direct inspection under the light microscope (laboratory method), to photomicrographs of glass slides with classroom projection (projection method). These methods have not been compared directly to date. Forty‐one second‐year medical students participated in this pilot study, a prospective, randomized, crossover study measuring educational performance during a hematology pathophysiology course. The students were randomized to one of two groups. All students received the same didactic lectures in the classroom and subsequent case‐based review of peripheral blood smears using either laboratory or projection methods, on day one with a crossover to the other method on day two. Pre‐ and post‐test examinations centered on morphology recognition measured educational performance on each day, followed by a questionnaire identifying the student's favored method. There was no significant difference in the pre‐test and post‐test scores between the two teaching methods (rank‐sum P = 0.43). Students overwhelmingly preferred the projection method and perceived it as superior (76%), although post‐test scores were not significantly different. Student's recommended method was split with 50% favoring the projection method, 43% favoring a combined approach, and 23% noting logistical challenges to the laboratory. In this study, the laboratory and projection method were equivalent in terms of educational performance for hematopathology among medicals students. A classroom‐based approach such as the projection method is favored, given the large class sizes in undergraduate medical education, as well as the ergonomic challenges and additional resources required for large group instruction in a laboratory setting. Anat Sci Educ 7: 130–134. © 2013 American Association of Anatomists.